Publication:
A Comparative Efficacy and Adverse Clinical Events of Methotrexate versus Azathioprine with Steroid Mini Pulse Therapy in the Management of Moderate to Severe Alopecia Areata: A Tertiary Centre Based Interventional Study

creativeworkseries.issnISSN 2091-0231 eISSN 2091-167X
dc.contributor.authorMishra, Aditi
dc.contributor.authorKC, Shekhar
dc.contributor.authorShrestha, Elisha
dc.contributor.authorPandey, Chandranshu
dc.contributor.authorKarn, Dharmendra
dc.date.accessioned2025-09-23T09:22:10Z
dc.date.available2025-09-23T09:22:10Z
dc.date.issued2022
dc.descriptionAditi Mishra Kathmandu University School of Medical Sciences (KUSMS), Dhulikhel, Nepal https://orcid.org/0000-0002-1758-2153 Shekhar KC Kathmandu University School of Medical Sciences (KUSMS), Dhulikhel, Nepal Elisha Shrestha Kathmandu University School of Medical Sciences (KUSMS), Dhulikhel, Nepal https://orcid.org/0000-0003-1337-7977 Chandranshu Pandey Kathmandu University School of Medical Sciences (KUSMS), Dhulikhel, Nepal Dharmendra Karn Kathmandu University School of Medical Sciences (KUSMS), Dhulikhel, Nepal
dc.description.abstractAbstract: Introduction: Alopecia areata is a T cell-mediated autoimmune disorder of hair follicles resulting in partial or total hair loss. Treatment of alopecia areata is difficult, and it has variable severity. Objectives: To compare the clinical efficacy and adverse clinical events of azathioprine versus methotrexate with steroid minipulse therapy in managing moderate to severe alopecia areata. Materials and Methods: Prospective non-blinded clinical trial conducted for 6 months in Department of Dermatology at Dhulikhel Hospital. Dermoscopic evidence of alopecia areata patients treated according to group assigned and effects and adverse event were noted. Results: There was a total of 36 patients enrolled. Twenty patients were in Group A (AZT+MPT) and 16 in group B (MTX+MPT). There was a significant improvement in SALT score at 6 months (Group A p-value: 0.03; group B p-value: 0.001). Treatment efficacy (percent scalp hair regrowth) in group A was 79.2%, and in group B was 89.01%. Conclusion: Both treatment regimens showed marked improvement with SALT score reduction; however, methotrexate with steroid minipulse therapy showed slightly higher treatment efficacy than azathioprine with steroid minipulse therapy.
dc.identifierhttps://doi.org/10.3126/njdvl.v20i1.42453
dc.identifier.urihttps://hdl.handle.net/20.500.14572/2293
dc.language.isoen_US
dc.publisherSociety of Dermatologists, Venereologists and Leprologists of Nepal (SODVELON)
dc.subjectAlopecia areata
dc.subjectAzathioprine
dc.subjectMethotrexate
dc.titleA Comparative Efficacy and Adverse Clinical Events of Methotrexate versus Azathioprine with Steroid Mini Pulse Therapy in the Management of Moderate to Severe Alopecia Areata: A Tertiary Centre Based Interventional Study
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage33
oaire.citation.startPage29
relation.isJournalIssueOfPublicationbf5571c1-ca9d-4748-9d35-886ab11359cf
relation.isJournalIssueOfPublication.latestForDiscoverybf5571c1-ca9d-4748-9d35-886ab11359cf
relation.isJournalOfPublicationb2ab7aab-75b0-4bd1-9ed0-b8a91c68201a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
29-33.pdf
Size:
2.84 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections